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CD8 T cells are essential for control of Toxoplasma gondii infection. Once activated they undergo diﬀerentiation into short-lived
eﬀector and memory precursor eﬀector cells. As eﬀector cells, CD8 T cells exert immune pressure on the parasite via production
of inﬂammatory cytokines and through their cytolytic activity. Once immune control has been established, the parasite encysts
and develops into chronic infection regulated by the memory CD8 T-cell population. Several signals are needed for this process
to be initiated and for development of fully diﬀerentiated memory CD8 T cells. With newly developed tools including CD8 T-
cell tetramers and TCR transgenic mice, dissecting the biology behind T. gondii-speciﬁc CD8 T-cell responses can now be more
eﬀectively addressed. In this paper, we discuss what is known about the signals required for eﬀective T. gondii-speciﬁc CD8 T-cell
development, their diﬀerentiation, and eﬀector function.
1.Introduction
Immune protection against many intracellular pathogens
including viruses, bacteria, and protozoa is provided by
robust CD8 T-cell responses. Na¨ ıve CD8 T cells are found
in lymphoid tissues where, after infection, they encounter
an antigen-presenting cell (APC) [1]. The APC presents
pathogen-derived antigens and provides the appropriate
costimulatorysignalstotheTcelltocausetheiractivation [2,
3]. This activation leads to the proliferation, diﬀerentiation,
and acquisition of eﬀector functions of the antigen-speciﬁc
CD8 T cell. Activated antigen-speciﬁc CD8 T-cell eﬀector
functions includesecretion ofcytokinesIFNγ and TNFαand
cytotoxicity,which promotefurtherdevelopmentofadaptive
immunity and control pathogens.
Original work by Frenkel revealed that antibodies, when
transferred from infected to na¨ ıve hamsters, provided little
protection against acute disease in the latter [4]. As such,
he adoptively transferred intact or lysed spleen cells from
infected animals to na¨ ıve animals then challenged them. He
found that only intact cells were able to confer immunity to
the recipient animals. Later, using the ts-4 model of infection
developed by E. R. Pfeﬀe r k o r na n dL .C .P f e ﬀerkorn [5],
Suzuki and Remington [6] further dissected this immunity.
Using an antibody depletion strategy with anti-CD4 and
anti-CD8, they showed that both CD4 and CD8 T cells
were important for control of infection with CD8 T cells
playing the dominant role [6]. Further studies by this group
using a similar strategy with anti-IFNγ and adoptive transfer
of CD8 T cells identiﬁed that IFNγ w a sam a j o rm e d i a t o r
of disease [7]. A short time later Khan and colleagues
developedtheﬁrst antigen-speciﬁc CD8Tcell clonescapable
of responding and killing T. gondii tachyzoites in vitro via
their cytotoxic activity [8]. These studies suggested that two
eﬀector mechanisms may be at play in controlling T. gondii
infection, IFNγ activation of macrophages, and cytotoxicity
mediated by CD8 T cells. Subsequent studies reinforced the
hypothesis that CD8 T cells were the dominant eﬀector cell
for control of T. gondii and were the source of IFNγ [9].
Toxoplasma gondii is an obligate intracellular parasite
of the phylum apicomplexa which infects approximately
30–80% of humans world wide [10]. Primary infection
during pregnancy causes severe birth defects and blindness
in the developing fetus [11]. Infection of adults is largely
asymptomatic during the acute stage of infection and once
disseminated encysts in immune privileged sites including
t h eb r a i nw h e r ei tp e r s i s t sf o rt h el i f eo ft h eh o s t .H o w -
ever, with loss of immune competence from HIV/AIDs or
immunosuppressive therapies, the parasite can reactivate.
Reactivation of the infection in the central nervous system
results in the development of encephalitis termed toxoplas-
mic encephalitis (TE) and causes death of the host.2 Journal of Parasitology Research
T. gondii population structure can be generally divided
into three clonal types based on virulence in mice [12, 13].
Recent studies now indicate that this population structure is
much more diverse in places such as rural South America
and in Africa with this diversity associated with increased
risk of primary and reactive ocular toxoplasmosis [14–
16]. Separately, T. gondii is also now being correlated
with increased risk of personality changes and potentially
enhanced development of dementia and Alzheimer’s disease
in the elderly [17–22]. Therefore, beyond developmentofTE
in immunocompromised patients, immune-competent indi-
viduals may be at higher risk for complications associated
with this infection.
Sincethesediscoveriesweremade,thecomplexitybehind
activation, development, and diﬀerentiation of CD8 T cells
into eﬀector and memory cells and their functions in
disease has increased greatly. In this paper, we present
current knowledge of how signal one (antigen recognition),
signal two (costimulation), and signal 3 (cytokines) aﬀect
activation of CD8 T-cell responses to T. gondii infection. We
also review CD8 T-cell eﬀector functions, the identiﬁcation
of diﬀerent phenotypes of CD8 T cell, and how they may
inﬂuence the pathogenes i so ft h i sd i s e a s e .
2.Generationof CD8T-CellResponses
2.1. Signal One: Antigen Presentation and Recognition. One
important cell-cell interaction between the APC and the
CD8 T cell needed for activation is recognition of antigen
presented on MHC Class I. Early studies using inbred and
outbred mouse strains showed that there were diﬀerent
susceptibilities to T. gondii infection suggesting that beyond
diﬀerences in inﬂammatory responses, a genetic compo-
nent could inﬂuence the control of the parasite [23–25].
Susceptibility was shown to be controlled by MHC Class I
haplotype by using mice with mutated and knockout mice
for the Ld allele [26–28]. Mice that possess this allele are
protected (Balb/c), while mice that are H-2b (C57BL/6) are
susceptibletoinfection.ThisallelespeciﬁcityforcontrolofT.
gondii is also found within humans as shown by using mice
expressing human MHC Class I transgenes [29]. Therefore,
MHC Class I haplotype is important for the generation of
optimal antigen-speciﬁc CD8 T-cell responses to T. gondii
infection.
Antigen speciﬁcity is vital for the study of CD8 T-cell
responses regardless of infection. For this reason, transgenic
parasites expressing the model antigen ovalbumin have
been developed [30]. While ova-transgenic parasites permit
tracking of ovalbumin-speciﬁc CD8 T cells, recent studies in
other models have suggested that pMHC-TCR avidity and
aﬃnity determine T-cell fate and functionality [31, 32]. This
bears the implication that examining CD8 responses against
ova, an exogenous protein may be useful for dissecting
general CD8 biology; however, the insights gained from
such a study may not necessarily be entirely applicable to
the dynamics and quality of CD8 T-cell response speciﬁc
for epitopes native to T. gondii. Recently, several T. gondii-
speciﬁc antigens have been identiﬁed to be the source of
peptides controlling dominant CD8 T-cell responses during
infection. These include peptides derived from parasite
proteins GRA6 (HF10), Tgd057, GRA4, and ROP7 [33–
35]. Also, using epigenetic reprogramming by somatic cell
nuclear transfer (SCNT) with CD8 T cells from T. gondii-
infected mice, a CD8 T-cell TCR transgenic mouse has been
developed for a parasite dominant antigen [36]. Despite
the development of these tools, major questions remain
including how eﬀective these deﬁned dominant CD8 T-cell
responses are for control of infection as individuals and are
CD8Tcellsspeciﬁc formultipletargetsneededforimmunity
to this infection. For example, although HF10 peptide-
BMDC immunization promoted survival against challenge
infection, parasite burden was not measured [33]. Therefore,
didthisimmunizationreducetheoverallparasiteburdenand
developmentofchronicinfection?GRA4-andROP7-derived
peptides also identify and stimulate signiﬁcant antigen-
speciﬁc CD8 T-cell responses after infection; however,
whether these CD8 T-cell clones are eﬀective at protection
has not been tested [34]. Similarly, Tgd057 and the T. gondii
TCR transgenic CD8 T cells have not been tested for direct
control of the parasite in vivo despite providing increased
survival after infection [35, 36]. The TCR transgenic CD8 T
cells only prevent around 50–60% survival against challenge
when adoptively transferred into na¨ ıve mice. Tgd057 CD8
T cells comprise only 2-3% of brain CD8 T cells and since
access to the brain by CD8 T cells is restricted to antigen-
speciﬁc cells only [37], this suggests that multiple epitopes
are likely required for control of chronic T. gondii infection.
Regardless, tetramer and transgenic TCR-based CD8 T-cell
tracking will permit Toxoplasma immunologists to address
complex questions regarding parasite-speciﬁc CD8 biology
that could not be addressed as thoroughly before. The
development of these tools will be essential for the future
study of CD8 T-cell responses to T. gondii infection.
2.2. Signal Two: Costimulation. A second cell-cell interaction
important for proper CD8 T-cell activation is mediated
via costimulatory/coinhibitory molecules. In addition to
recognition of antigen presented by the MHC class I
molecules, CD8 and CD4 T cells require costimulation by
the APC to become fully activated [1, 2]. Costimulation
occurs mainly via interaction of two families of proteins, the
immunoglobulin (Ig) superfamily members B7/CD28 and
the TNFR/TNF superfamily of proteins [3]. Regulation of
costimulationandthusthelevelsofCD8T-cellactivationcan
also occur via these families of proteins, more speciﬁcally by
CD28 homolog cytotoxic T-lymphocytes-associated antigen
4 (CTLA4), inducible T-cell costimulator (ICOS), and pro-
grammed cell death 1 (PD1) [3, 38, 39]. Early investigations
of how costimulation aﬀects T-cell activation in response
to T. gondii showed that CD86 played a more dominant
role in this process [40]. Using human PBMCs, use of anti-
CD86 reduced the level of T-cell activation in response to T.
gondii stimulation whereas anit-CD80 had less eﬀect. Using
this same strategy, CD40 and CD40L were shown to play an
important role in the activation of human T cells in response
to T. gondii [41]. Interestingly, subsequent studies in mice
revealed that CD28, a receptor for CD80 and CD86, was
not required to generate T-cell responses yet contributed toJournal of Parasitology Research 3
the immunopathology in the brain [42]. Although there is
no reduction in activation of T cells, CD28-deﬁcient mice
had a reduced ability to recall to subsequent challenge. In
the following studies, CD86/CD28 and CD40/CD40L were
found to control the acute inﬂammation and pathology in
IL-10-deﬁcient mice [43] suggesting that they may play a
role in normal T-cell responses to T. gondii infection. Given
thatCD28-deﬁcientmiceappearedtoberesistant to T. gondii
infection,CD28-independentresponses wereinvestigatedfor
their role in T-cell activation to parasite infection. These
studiesfocusedontheinduciblecostimulatorprotein(ICOS)
as it is homologous to CD28. Unlike CD28, however, ICOS
is an inducible costimulatory molecule for T-cell activation
[44]. Despite CD28-deﬁcient animals being resistant to T.
gondii infection, blockade of ICOS in vivo made these mice
more susceptible to infection by reducing the proliferation
and level of IFNγ production by T cells [45]. Despite a lack
of strong support for CD28 in the activation of T cells to T.
gondii infection, recent studies using protein kinase c-theta-
(PKC-θ-) deﬁcient mice have shown that this molecule is
essential for both CD4 and CD8 T-cell activation against
this parasite [46]. PKC-θ is recruited into microclusters
TCR/CD28by CD28allowing forthe initial signaling needed
for T-cell activation [47]. CD28 then retains PKC-θ in
a subregion causing sustained signaling. Taken together
whetherornotCD28isrequiredforactivationofCD8Tcells
in response to T. gondii is still unclear; however, based on the
PKC-θ-deﬁcientmouseresults, furtherexplorationisneeded
tofullyunderstandthesesignalingmoleculesindevelopment
of CD8 T-cell immunity to this parasite. Overall, little
is known about costimulation and CD8 T-cell activation
in response to T. gondii infection. As the complexities
behind the development of quality of CD8 T cells grow,
understanding the mechanisms behind costimulation and
coinhibition is an important area of investigation.
2.3. Signal Three: Cytokines. Several stimuli are required for
the activation of CD8 T cells to proliferate and diﬀerentiate.
Apart from antigen recognition and costimulation, signal
3, the cytokine milieu, plays a critical role in this process.
Signal 3 is produced by many diﬀerent cell types, and there
are several inﬂammatory cell types that inﬁltrate into the
site of infection and exert their function during T. gondii
infection [48]. These are neutrophils (PMNs), macrophages,
and dendritic cells. Each of these cell types contributes to the
immune response against infection by providing cytokines
and chemokines, toxoplasma-static and -cidal mechanisms
of control, and in the case of macrophages and DCs, antigen
presentation [49–57]. A key cytokine produced by these cells
during initial infection and that is required for initiation of
CD8 T-cell responses against T. gondii infection is IL-12 [58–
61].IL-12isaheterodimericproteinformedbytwosubunits,
IL-12p40 and IL-12p35, and when assembled together form
thebiologicallyactiveformofIL-12deﬁnedasIL-12p70[62].
IL-12p70 can induce activation of NK and T cells to produce
IFNγ via a JAK/STAT-dependent pathway [58, 59, 63, 64].
Virulence level of T. gondii can alter the amount of IL-12p70
heterodimer and IL-12p40 monomer produced by diﬀerent
innate eﬀector cells [65]. This likely leads to diﬀerences
in the quality of CD8 T-cell responses produced, as with
highly virulent strains, CD8 responses are largely impaired
and correlate with high level IL-12p40 production [66]. This
hypothesis is supported by work in other infection models
showing that IL-12 inﬂuences the diﬀerentiation of newly
activated CD8 T cells leading to diﬀerent levels of CD8 T-
cell memory development [67, 68]. Recent investigations of
the function of IL-12 in CD8 T-cell diﬀerentiation during T.
gondii infection largely support that this cytokine is vital for
this process [69].
Several cytokines, other than IL-12, are important for
CD8T-cell functioninresponse toT. gondii infection includ-
ing common-cytokine-receptor γ-chain cytokines including
IL-2,IL-7,andIL-15.WhetherornotIL-2playsaroleinCD8
T-cell activation in response to T. gondii remains unknown.
Very little work has been done to investigate the function of
IL-7 in the development of CD8 T-cell responses. IL-15, a
member of the common-cytokine-receptorγ-chain family of
cytokines, is important for the maintenance of long-lasting
high avidity memory CD8 T-cell populations [70]. IL-15 has
been shown to enhance CD8 T-cell responses, and blockade
of this cytokine with a soluble receptor abrogates immunity
[71–73]. Surprisingly, IL-15 knockout mice survive as well
as wild type mice when infected with T. gondii [74, 75].
However, in the absence of both IL-7 and IL-15, CD8 T-cell
responses areseverelyimpairedandmicedonotsurvive[76].
In additionto cytokines, interactions with APCsare also very
important in the activation of CD8 T cells.
2.4. Eﬀector Function and Diﬀerentiation of CD8 T Cells.
The downstream consequence of properly coordinated Th1
activation signals is the development of robust long-term
CD8 T-cell memory. After activation of na¨ ıve CD8 T cells
during an infection, they rapidly proliferate and diﬀerentiate
into a heterogeneous population of eﬀector cells composed
of terminally diﬀerentiated eﬀector cells termed short-lived
eﬀector cells (SLECs) and cells that are more long lived
and are the precursors to memory cells termed memory
precursor cells (MPECs) [77]. The SLECs typically provide
the mechanism of control via their production of eﬀector
molecules including cytokines and cytolysis. After this initial
expansion and diﬀerentiation, the pool of activated CD8
T cells undergoes a process termed contraction where the
terminally diﬀerentiated SLECs apoptose leaving behind the
smallersubsetofMPECs[77].Thesememoryprecursorsfur-
ther diﬀerentiate into bona ﬁde memory cells that undergo
homeostatic proliferation and continually renew themselves.
Many factors includingantigen exposure, costimulation,and
the level of inﬂammation inﬂuence the path these cells take.
The mechanisms governing these processes are a major focus
in immunology and are only now beginning to be addressed
in the T. gondii ﬁeld.
2.5. CD8 T-Cell Eﬀector Function. The major mediator of
resistance to T. gondii infection is IFNγ [7]. IFNγ can
be produced by several cell types in response to parasite
infection including NK, NKT, γδ T, CD4, and CD8 T cells
[9, 58, 78–81]. CD8 T-cell production of this cytokine is
essential for their ability to control the parasite [9]. IFNγ4 Journal of Parasitology Research
producedby CD8T cellsactsonsurrounding cells, including
macrophages, which in turn inhibits the proliferation of
the parasite via induction of inducible nitric oxide synthase
(iNOS) and indoleamine 2,3-dioxygenase (IDO) [54, 82–
90]. These two enzymes control the parasite via toxicity of
nitric oxide and starvation of the parasite by removal of the
amino acids L-arginine and tryptophan for which T. gondii
has a natural auxotrophy [86, 91]. CD8 T cells produce IFNγ
in response to IL-12-induced T-bet expression [59, 61, 67,
69]. Kinetically, CD8 T-cell production of IFNγ begins 2-3
days after parasite infection with eventual contraction out
to 21 days after infection followed by low numbers being
maintained [66, 69, 92]. CD8 T-cell-derived IFNγ then is
likely to have two roles in controlling the parasite, initially
during acute infection to reduce parasite numbers and then
during chronic infection to exert immune pressure suﬃcient
to maintain the parasite encysted as a bradyzoite. This has
been previously established where anti-IFNγ-treated WT or
IFNγ KO (GKO) mice result in death 8 days later due to
uncontrolled acute infection, and anti-IFNγ treatment of
chronically infected mice results in reactivation of encysted
parasites [7, 48, 93, 94]. Interestingly, we and others have
found that only exceedingly high levels of anti-IFNγ and
upwards of 6mg/mouse are required to cause parasite
reactivation [93]. Even in cases where this reactivation
is initiated, we have noticed that mice recover from this
treatment (unpublished observations). Therefore, additional
CD8 T-cell eﬀector mechanisms are likely required for the
control of the parasite in both acute and chronic infections.
Another interesting question remaining to be answered
i sw h e t h e ro rn o tI F N γ is required for the development
of CD8 T-cell responses during T. gondii infection. IFNγ
is known to signal through STAT1 resulting in T-bet-
dependent upregulation of the IL-12Rβ1[ 95]. Therefore,
IFNγ, in an autocrine fashion, may also be important for
CD8 T-cell diﬀerentiation. Investigation of this possibility
could be done with the current parasite tools and IFNγR1
KO mice.
CD8 T cells can also provide eﬀector function via the
production of other cytokines including TNFα and through
their cytolytic abilities [96]. The role of TNFα in the control
of T. gondii infection was shown early on to be synergistic
with IFNγ [97]. For macrophages to control the growth
and replication of T. gondii parasites, they ﬁrst needed
priming by IFNγ then required TNFα. A second study
investigated whether the lack of TNFα had an eﬀect on the
survival ofeithertoxoplasmicencephalitis- (TE-)resistant or
susceptible mice [98]. This study revealed that when infected
per orally, C57BL/6 mice died when treated with anti-
TNFα. However, in a TE-resistant strain of mice, anti-TNFα
treatment had no eﬀect. An additional study investigating
the cause of TE in mice revealed that TNFα transcripts
were elevated after infection in the brain [99]. As the mice
succumbed to TE, the level of speciﬁc mRNA transcripts,
including TNFα, was reduced. Therefore, they treated mice
with anti-TNFα after chronic infection was established (4
weeks p.i.) and measured their survival. Interestingly, they
found that treatment with anti-TNFα caused reactivation
of T. gondii as quickly as anti-IFNγ treatment, suggesting
that this cytokine played an important role in the control
of T. gondii as the latter. Subsequent studies showed that
theTNFα-dependentantitoxoplasmaeﬀectwasderivedfrom
both hematopoietic and nonhematopoietic sources [100–
103]. Combined together, these studies reveal an important
function of TNFα in the control of T. gondii parasites and
development of TE in mice. However, whether CD8 T cells
are directly producing this TNFα in response to infection
has not been tested. Deﬁning which CD8 T-cell populations
are important for delivering this eﬀector function will be
important to address in future studies.
CD8 T cells have been shown to directly kill extracellular
tachyzoites of T. gondii in culture [8]. CTL clones and CTLs
from mice vaccinated with the temperature-sensitive mutant
(ts-4) were also able to kill parasitized and parasite antigen-
pulsed target cells in vitro [104, 105]. Cytotoxicity is also
exhibited by human CD8 T cells and can kill antigen-pulsed
cells in vitro [106, 107]. Despite the ﬁndings from these
papers, the role of the cytotoxic CD8 T cell in the control of
T. gondii infection is still unclear. Although immunization
of perforin knockout mice (PKO) resulted in defective
cytolysis of antigen-pulsed target cells, when challenged with
a type I strain of parasite, these mice survived challenge
infection [108]. Subsequent studies have supported these
ﬁndings and have shown that IFNγ not perforin or CTL
activity is required for immune protection against T, gondii
infection [109]. Recent studies using an antigen-speciﬁc
OVA transgenic parasite system and perforin knockout mice
suggest that the more prominent mechanism of CTL activity
was perforin dependent in vivo and that Fas-FasL played a
subordinate role[92].Althoughthisstudydidnotinvestigate
whether perforin and CTL activity was a major mechanism
of control, a subsequent study reports that adoptive transfer
of immune CD8 T cells into chronically infected SCID mice
(treated with sulfadiazine to establish chronic infection)
controlled and removed encysted parasites in the brain via
a perforin-dependent mechanism [110]. Taken together,
research of eﬀector functions of CD8 T cells important for
the control of T. gondii infection has clearly established that
IFNγ is required. Whether or not TNFα or CTL activity is
needed for initial control, for development of CD8 memory,
or required for long-term control of chronic infection needs
more investigation. With new tools to track antigen-speciﬁc
CD8 T cells including TCR transgenic mice and transgenic
parasites expressing OVA protein, investigations of what
roles diﬀerent eﬀector mechanisms play in control of T.
gondii are now feasible.
3.RolesofSLECand MPECin
T. gondii Infection
SLEC and MPEC can be generally distinguished by their
phenotype based on their surface expression of Killer cell
lectin-like receptor G1 (KLRG1) and IL-7Rα (IL-7R) [68].
SLECs are deﬁned as being KLRG1hi and IL-7RIo whereas
MPECs are KLRG1Io IL-7Rhi. Despite their diﬀerence in
phenotype, these CD8 T-cell populations produce similar
levelsofeﬀectorfunctions includingIFNγ,c yt o t o x i ca c t i vi ty ,
and proliferation [68]. Interestingly, the level of IL-12 hadJournal of Parasitology Research 5
apr ofoundeﬀectontheirdevelopment.Previousstudieshad
s h o wnth a ti nth ea bs en c eofIL - 12,CD8Tc ellsdi ﬀerentiated
into more memory cells after infection with Listeria monocy-
togenes [67]. Similar to this study, Joshi et al. [68]s h o w e d
that the level of IL-12 correlated with the amount of the Th1
transcription factor T-bet and that higher T bet resulted in
greater SLEC and less MPEC diﬀerentiation. The converse
was also true in that lower levels of IL-12 resulted in higher
MPEC and lower SLEC diﬀerentiation. Original studies
with T. gondii broadly deﬁned eﬀector populations by their
ability to proliferate, be cytotoxic, and produce IFNγ and
memory populations on their ability to recall to challenge or
antigen. Recent work on CD8 T-cell eﬀector diﬀerentiation
in response to T. gondii has revealed that IL-12 is required
for SLEC generation [69]. This study agrees with previously
published reports using other models of infection that in
the absence of IL-12 using IL-12p35KO mice, MPECs were
presentatahigherfrequencythanSLECs.TheT. gondii study,
however, showed that eﬀector generation was solely depen-
dent upon CD8 T-cell intrinsic IL-12 signaling and unlike
viral and bacterial models was independent of CD4 T-cell
help [69]. This is also in contrast to a previous report using
OVA-expressing transgenic parasites where CD4 T-cell help
was reported to be required for eﬀector CD8 T-cell genera-
tion [92]. Regardless, the generation of SLEC and MPEC in
response to T. gondii infectionappearstobesolely dependent
upon intrinsic IL-12 signaling. As parasite virulencecan alter
the levels and types of IL-12 produced during infection, one
mechanism of escape may be via the overproduction of IL-
12, thereby inhibiting the development of MPEC important
for the control of chronic infection. Recent reports may
support this hypothesis where treatment of mice with rIL-
12p70partially rescuesantigen-speciﬁc CD8T-cell responses
in mice infected with highly virulent parasite strain [111].
SLECs required IL-15 for survival in response to LCMV
infection most likely due to their inability to receive pro-
survival signals from IL-7 because of their low expression
of IL-7R [68]. IL-15 knockout mice have been shown to
be able to survive T. gondii infection as well as WT mice
with near normal activation of their CD8 T cells [66, 74,
76]. Interestingly, CD4 T-cell priming is defective in these
mice [75]. During T. gondii infection, CD8 T-cell activation
does not require CD4 T-cell help; however, CD4 T cells are
required to maintain memory CD8 T-cell responses [112].
It is surprising then that IL-15 KO mice do not succumb
more rapidly to long-term infection with T. gondii,g i v e n
that CD4 T-cell help has been shown to be required for
long-term CD8 T-cell memory responses to LCMV and
Listeria monocytogenes [113, 114]. One possible explanation
for these results could be a result of the mouse strain used
for these studies. C57BL/6 mice are most often used to
study basic immunology in response to T. gondii.T h e ya r e
inherently unable to fully control the parasite due to their
MHC Class I allele [27, 28]. Due to this defect, they may
be less eﬃcient at developing memory CD8 T-cell responses
while having continuous generation of SLEC responses. A
lack of memory CD8 T-cell diﬀerentiation could explain
then the susceptibility of these mice, a result of the eventual
development of exhaustion in the responding CD8 T-cell
population [115]. Major questions still need to be addressed
about which CD8 population (SLEC or MPEC) is important
for ultimate control of the parasite and how this relates
to evasion of the parasite from immune surveillance. With
the recent identiﬁcation of dominant antigens and tools
for detecting antigen-speciﬁc CD8 T cells, investigation of
how CD8 T cells are activated, how they undergo their
initial diﬀerentiation, and which population is important in
controlling infection will be much easier [33–36].
4.ConcludingRemarks
There is little doubt that CD8 T cells are central for the con-
trol of T. gondii infection and, in particular, their production
of IFNγ. Many factors play a role in the development of
this response; however, the body of knowledge behind CD8
T-cell responses to T. gondii infection to date remains very
superﬁcial especially in regard to the molecular mechanisms
behind their initial activation, diﬀerentiation, and memory
development. Given the breadth of information on the
complexities underlying the biology of CD8 T cells obtained
using other intracellular pathogens including bacterial and
viral models of infection, major gaps exist in the current
understanding of their role in T. gondii infection. Many
questions still exist in areas such as, but not restricted to,
( 1 )h o wt h ea r r a yo fr e c o g n i z a b l ea n t i g e n st h a ts t i m u l a t e
CD8 T cells aﬀects this response, (2) how signals 1, 2,
and 3 alter the diﬀerentiation of the diﬀerent CD8 T-
cell subpopulations, (3) molecular pathways involved in
the programming of these cells, (4) the required eﬀector
functions and when and where they are important, (5) the
role of accessory cells including CD4 T-cell help, and (6)
the identiﬁcation of mechanisms behind the development
and maintenance of eﬀector memory and central memory
CD8 T-cells populations. Additional areas are in need of
investigation center on how parasite biology can aﬀect this
response. Protozoan biology is exceedingly complex and can
profoundly inﬂuence the response of the host and represents
a major barrier in the development of immunity. How
these parasite mechanisms alter host immunity and how
this aﬀects development of CD8 T-cell eﬀector function and
memory is unknown. The evidence for this parasite-driven
immune evasion is present in that despite the development
of powerful strategies to create a vaccine against this disease,
the parasite continually escapes and establishes a chronic
infection. Therefore, further investigation is needed to dis-
sect both host and parasite biologyto aid in the development
of CD8 T-cell-based immunotherapies against this disease.
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